Finally, Light at the End of the Pandemic

Medical technicians work at a drive-through coronavirus testing facility at Regeneron Pharmaceuticals’s Westchester campus in Tarrytown, N.Y., September 17, 2020. (Brendan McDermid/Reuters)
Rapid improvements in prevention and treatment could end the pandemic sooner than people think.

NRPLUS MEMBER ARTICLE W hen the announcement came on October 2 that President Trump had tested positive for COVID-19, his supporters — and more than a few critics — prayed for his speedy recovery. At the age of 74 and with at least one significant comorbidity, Trump was at high risk of a severe and potentially fatal bout of COVID-19.

Little did he or anyone else know, his timing could not have been better. Just three days earlier, a company called Regeneron Pharmaceuticals announced that clinical trials of its futuristic new treatment had succeeded in reducing both infection and the time it takes for alleviation

Mario Loyola — Mr. Loyola is a research associate professor and the director of the Environmental Finance and Risk Management Program at Florida International University and a senior fellow at the Competitive Enterprise Institute. From 2017 to 2019 he was the associate director for regulatory reform at the White House Council on Environmental Quality.

Recommended

The Latest